GlassScriptPhysician profile
Moustafa M Ali
NPI 1124122270
$1,398.73
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,150 · 2020: $104 · 2021: $17.41 · 2023: $51.37 · 2024: $75.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $706.83 | 2019 | |
| Abbvie INC. | $82.59 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $77.61 | 2019 | |
| Minerva Surgical, INC | $75.90 | 2024 | |
| Merck Sharp & Dohme LLC | $67.66 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.21 | 2019-2020 | |
| Pfizer INC. | $53.91 | 2019-2021 | |
| Aspira Women'S Health INC | $51.37 | 2023 | Ova1 |
| Roche Diagnostics Corporation | $46.59 | 2019 | |
| Ethicon US, LLC | $38.01 | 2019 | |
| Allergan, INC. | $37.00 | 2019 | |
| Eisai INC. | $26.25 | 2020 | |
| Therapeuticsmd, INC. | $25.14 | 2019-2020 | |
| Coopersurgical, INC. | $14.45 | 2019 | |
| Lupin INC. | $14.29 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $13.72 | 2019 | |
| Dysis Medical, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moustafa Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.